Cabozantinib (CBZ) is a small molecule tyrosine kinase receptor inhibitor. which could also inhibit the ABCG2 transporter function. Therefore. CBZ could re-sensitize cancer cells that are resistant to ABCG2 substrate drugs including topotecan (TPT). https://fitnessgravesyardes.shop/product-category/plastic-cover/